ARCHIVES

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

On More Victory For Sol Garb: FDA Approves THC

June 14, 1985

ASCO Issues RFP To Establish Washington Office

August 11, 1989

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012